NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Countries with universal health systems where medications are kept far less expensive than they are in the USA, have a much greater incentive than the USA, to keep medical costs down.

I would imagine that in such countries the big global pharmaceutical companies have less political power than they have in the USA and would find it much more difficult to prevent a cheap but effective drug from entering the market so that they can sell their more expensive but less effective drugs.

So the fact that studies in the UK and Spain have not shown hydroxychloroquine to be effective in COVID-19 patients, suggests to me that this drug is in fact not effective. I do not believe that countries that are trying to keep medical costs down, would reject a cheap effective drug because they are in the pockets of BP. If trials in those countries would have shown hydroxychloroquine to be efficacious in COVID-19 patients, it would now be prescribed in those countries.


https://www.sciencemag.org/news/2020/06/three-big-studies-dim-hopes-hydroxychloroquine-can-treat-or-prevent-covid-19